Want to see NZ:CVT full AI Analyst Report?
Top Page
Comvita
(CVT)
Select Model
Select Model
Rating:67Neutral
Price Target:
$0.84
▲(7.05% Upside)
Action:N/A
Date:10/05/26
The score is driven primarily by improved financial performance (profitability returning, strong operating/free cash flow, and materially better leverage). Valuation is supportive with a low P/E, but technicals are only neutral-to-soft in the near term, and the earnings call highlights meaningful uncertainties (no FY27 guidance yet, China pressure, and North America margin compression) that temper confidence in the durability of the recovery.
Positive Factors
FY26 profitability and revenue recovery
The return to profitability alongside 10.8% revenue growth indicates that Comvita’s recovery is supported by both stronger demand and improved operating execution. Higher gross margin and positive EBIT create a more durable platform for reinvestment, brand development, and earnings growth over the next several quarters.
Negative Factors
Greater China demand and pricing pressure
Persistent softness and pricing pressure in Greater China threaten both sales quality and profitability in an important market. Commoditization and parallel imports can weaken brand differentiation, force discounting, and make it harder for Comvita to sustain premium pricing or restore regional returns quickly.
Read all positive and negative factors
Positive Factors
Negative Factors
FY26 profitability and revenue recovery
The return to profitability alongside 10.8% revenue growth indicates that Comvita’s recovery is supported by both stronger demand and improved operating execution. Higher gross margin and positive EBIT create a more durable platform for reinvestment, brand development, and earnings growth over the next several quarters.
Read all positive factors
Comvita (CVT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$99.98M
Dividend Yield1.9%
Average Volume (3M)26.00K
Price to Earnings (P/E)7.6
Beta (1Y)1.16
Revenue Growth10.67%
EPS GrowthN/A
CountryNZ
Employees395
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)N/A
Shares Outstanding129,839,040
10 Day Avg. Volume19,333
30 Day Avg. Volume26,003
Financial Highlights & Ratios
PEG Ratio-0.07
Price to Book (P/B)0.59
Price to Sales (P/S)0.27
P/FCF Ratio1.70
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Comvita Business Overview & Revenue Model
Company Description
Comvita Limited, along with its associated entities, specializes in the global production and distribution of natural health products. The company boasts a significant international presence, operating across diverse markets in Australasia, Asia (...
How the Company Makes Money
Comvita makes money primarily by manufacturing, branding, and selling natural health and wellness products, with Mānuka honey as its core revenue driver. The company’s revenue model is largely product-sales based: it sources/produces raw inputs (n...
Comvita Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
74
Positive
Cash Flow
69
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 212.96M | 192.43M | 200.68M | 234.19M | 209.09M |
| Gross Profit | 114.80M | 82.70M | 108.88M | 135.76M | 126.23M |
| EBITDA | 21.99M | -22.14M | -63.03M | 31.78M | 30.56M |
| Net Income | 7.74M | -104.76M | -77.39M | 11.06M | 12.78M |
Balance Sheet | |||||
| Total Assets | 164.88M | 173.35M | 307.86M | 358.77M | 332.78M |
| Cash, Cash Equivalents and Short-Term Investments | 13.00M | 9.00M | 8.16M | 11.55M | 17.76M |
| Total Debt | 30.54M | 91.70M | 109.42M | 80.30M | 56.10M |
| Total Liabilities | 68.06M | 118.45M | 147.23M | 119.45M | 104.79M |
| Stockholders Equity | 96.83M | 54.90M | 160.63M | 239.32M | 227.99M |
Cash Flow | |||||
| Free Cash Flow | 33.84M | 30.89M | -2.19M | -18.04M | -5.87M |
| Operating Cash Flow | 35.10M | 34.14M | 5.33M | 2.40M | 3.58M |
| Investing Cash Flow | -1.45M | -1.66M | -13.65M | -20.79M | -13.22M |
| Financing Cash Flow | -30.31M | -31.65M | 5.04M | 12.46M | 10.88M |
Comvita Technical Analysis
Neutral
0.78
Price Trends
0.78
Negative
0.74
Positive
0.69
Positive
Market Momentum
>-0.01
Positive
41.97
Neutral
38.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:CVT, the sentiment is Neutral. The current price of 0.78 is below the 20-day moving average (MA) of 0.79, below the 50-day MA of 0.78, and above the 200-day MA of 0.69, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 41.97 is Neutral, neither overbought nor oversold. The STOCH value of 38.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NZ:CVT.
Comvita Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $5.99B | 25.89 | 17.63% | 7.73% | 3.84% | 6.53% | |
67 Neutral | $99.98M | 7.56 | 9.98% | 1.90% | 10.67% | ― | |
66 Neutral | $598.44M | 8.18 | 9.48% | 1.84% | -4.16% | 91.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | $129.16M | -13.78 | -4.98% | 5.79% | ― | ― | |
46 Neutral | $244.30M | -3.62 | -10.58% | ― | -7.94% | -95.77% | |
46 Neutral | $10.76M | -3.38 | ― | ― | -12.36% | 79.80% |
* Consumer Defensive Sector Average
NZ:CVT
Comvita
0.75
-0.01
-1.57%
NZ:ATM
a2 Milk Company
8.01
-1.38
-14.68%
NZ:NZK
New Zealand King Salmon Investments
0.25
0.04
22.50%
NZ:SAN
Sanford
6.30
0.51
8.85%
NZ:SML
Synlait Milk Ltd.
0.42
-0.36
-46.15%
NZ:MEE
Me Today Limited
0.10
0.03
41.43%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.